Company Filing History:
6 out of 88 
2 out of 2,489 
2 out of 47 
Years Active: 2019-2024
Title: Guanguan Li: Innovator in Neuropharmacology
Introduction
Guanguan Li is a prominent inventor based in Milwaukee, WI, known for his significant contributions to neuropharmacology. With a total of six patents to his name, he has focused on developing innovative treatments for cognitive and mood symptoms associated with neurodegenerative and neuropsychiatric disorders.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAreceptor agonists." This patent provides novel alpha5-containing GABAreceptor agonists and outlines pharmaceutical compositions and methods for treating cognitive and mood symptoms in affected individuals. Another notable patent is for "Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators." This invention describes specific substituted benzo[f]imidazo[1,5-a][1,4]diazepines that target alpha-4 and alpha-5 GABAa receptors, proving useful in treating airway hyperresponsiveness and inflammation in asthma.
Career Highlights
Guanguan Li has had a distinguished career, working with reputable organizations such as the UWM Research Foundation, Inc. and Columbia University. His work has significantly advanced the understanding and treatment of various neuropsychiatric conditions.
Collabor